Ramsay Health Care Limited (ASX:RHC)
Australia · Delayed Price · Currency is AUD 54.64
+0.10 (0.18%)
Oct 9, 2026, 4:12 PM AEST
Ramsay Health Care Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 18,578 | 17,674 | 16,660 | 14,964 | 13,312 |
Other Revenue | 71.3 | 60.4 | - | - | - |
| 18,649 | 17,734 | 16,660 | 14,964 | 13,312 | |
Revenue Growth | 5.16% | 6.45% | 11.34% | 12.41% | 3.48% |
Cost of Revenue | 16,365 | 15,614 | 14,646 | 13,320 | 11,924 |
Gross Profit | 2,285 | 2,121 | 2,014 | 1,644 | 1,389 |
Other Operating Expenses | - | -29.2 | -111.9 | - | - |
Operating Expenses | 1,181 | 1,097 | 970.2 | 986.5 | 927.6 |
Operating Income | 1,103 | 1,024 | 1,044 | 657.6 | 460.9 |
Interest Expense | -608.4 | -621.8 | -620 | -514.2 | -389 |
Interest & Investment Income | 16.6 | 17.4 | 7 | 39.9 | 36.2 |
Earnings From Equity Investments | - | - | - | - | 0.2 |
EBT Excluding Unusual Items | 511.6 | 419.2 | 430.6 | 183.3 | 108.3 |
Merger & Restructuring Charges | 12 | -6.4 | - | - | - |
Impairment of Goodwill | - | -248.4 | - | - | - |
Gain (Loss) on Sale of Investments | 14 | - | - | - | - |
Gain (Loss) on Sale of Assets | -2 | 15.9 | - | 67.9 | 24.2 |
Asset Writedown | -22 | -78.5 | -46 | -14.3 | -11.3 |
Other Unusual Items | - | - | - | 290.2 | 402 |
Pretax Income | 513.6 | 101.8 | 384.6 | 527.1 | 523.2 |
Income Tax Expense | 192.2 | 55.5 | 121.3 | 181.5 | 159.3 |
Earnings From Continuing Operations | 321.4 | 46.3 | 263.3 | 345.6 | 363.9 |
Earnings From Discontinued Operations | - | - | 618.1 | 19.9 | 15.3 |
Net Income to Company | 321.4 | 46.3 | 881.4 | 365.5 | 379.2 |
Minority Interest in Earnings | 7.8 | -22.3 | 7.3 | -67.4 | -105.2 |
Net Income | 329.2 | 24 | 888.7 | 298.1 | 274 |
Preferred Dividends & Other Adjustments | 15.7 | 17.2 | 16.7 | 13 | 9 |
Net Income to Common | 313.5 | 6.8 | 872 | 285.1 | 265 |
Net Income Growth | 4510.29% | -99.22% | 205.86% | 7.58% | -39.76% |
Shares Outstanding (Basic) | 230 | 229 | 229 | 228 | 228 |
Shares Outstanding (Diluted) | 231 | 230 | 229 | 228 | 228 |
Shares Change | 0.35% | 0.48% | 0.22% | 0.04% | -0.04% |
EPS (Basic) | 1.36 | 0.03 | 3.82 | 1.25 | 1.16 |
EPS (Diluted) | 1.36 | 0.03 | 3.81 | 1.25 | 1.16 |
EPS Growth | 4481.34% | -99.22% | 205.20% | 7.50% | -39.72% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 696.5 | 704.2 | 539 | 558.7 | 7 |
Free Cash Flow Per Share | 3.02 | 3.06 | 2.35 | 2.45 | 0.03 |
Dividend Per Share | 0.910 | 0.800 | 0.800 | 0.750 | 0.970 |
Dividend Growth | 13.75% | 0% | 6.67% | -22.68% | -35.97% |
Gross Margin | 12.25% | 11.96% | 12.09% | 10.99% | 10.43% |
Operating Margin | 5.92% | 5.77% | 6.26% | 4.40% | 3.46% |
Profit Margin | 1.68% | 0.04% | 5.23% | 1.91% | 1.99% |
Free Cash Flow Margin | 3.74% | 3.97% | 3.23% | 3.73% | 0.05% |
EBITDA | 1,786 | 1,610 | 1,588 | 1,172 | 950.7 |
EBITDA Margin | 9.57% | 9.08% | 9.53% | 7.83% | 7.14% |
D&A For EBITDA | 682.1 | 586.3 | 544.3 | 514.3 | 489.8 |
EBIT | 1,103 | 1,024 | 1,044 | 657.6 | 460.9 |
EBIT Margin | 5.92% | 5.77% | 6.26% | 4.40% | 3.46% |
Effective Tax Rate | 37.42% | 54.52% | 31.54% | 34.43% | 30.45% |
Revenue as Reported | 18,707 | 17,797 | 16,779 | 15,369 | 13,776 |